Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer Progression

Author： Rad Ellie Murray James T. Tee Andrew R.

Publisher： MDPI

E-ISSN： 2072-6694|10|1|5-5

ISSN： 2072-6694

Source： Cancers, Vol.10, Iss.1, 2018-01, pp. : 5-5

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

By Dufour Marc Dormond-Meuwly Anne Demartines Nicolas Dormond Olivier

Cancers, Vol. 3, Iss. 2, 2011-05 ,pp. : 2478-2500

MDPI

Access to resources Recommend Favorite

The mTOR Signalling Pathway in Human Cancer

By Pópulo Helena Lopes José Manuel Soares Paula

International Journal of Molecular Sciences, Vol. 13, Iss. 2, 2012-02 ,pp. : 1886-1918

MDPI

Access to resources Recommend Favorite

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis

By Lawrence Jessica Nho Richard

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 778-778

MDPI

Access to resources Recommend Favorite

mTOR Pathways in Cancer and Autophagy

By Paquette Mathieu El-Houjeiri Leeanna Pause Arnim

Cancers, Vol. 10, Iss. 1, 2018-01 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif Hashimi Saeed M. Wei Ming Q.

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite